DE3013502C2 - [2''-(Trifluormethyl)-phenthiazin-10''-yl-(n-prop-3'''ylpiperazin-4''''-yläth-2'''''-yl)]-ester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel - Google Patents
[2''-(Trifluormethyl)-phenthiazin-10''-yl-(n-prop-3'''ylpiperazin-4''''-yläth-2'''''-yl)]-ester, Verfahren zur Herstellung derselben und diese enthaltende ArzneimittelInfo
- Publication number
- DE3013502C2 DE3013502C2 DE3013502A DE3013502A DE3013502C2 DE 3013502 C2 DE3013502 C2 DE 3013502C2 DE 3013502 A DE3013502 A DE 3013502A DE 3013502 A DE3013502 A DE 3013502A DE 3013502 C2 DE3013502 C2 DE 3013502C2
- Authority
- DE
- Germany
- Prior art keywords
- trifluoromethyl
- prop
- ylpiperazin
- ester
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
- C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79GO1442A HU179190B (en) | 1979-04-06 | 1979-04-06 | Process for preparing new phenthiazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3013502A1 DE3013502A1 (de) | 1980-10-16 |
DE3013502C2 true DE3013502C2 (de) | 1985-02-07 |
Family
ID=10996889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3013502A Expired DE3013502C2 (de) | 1979-04-06 | 1980-04-08 | [2''-(Trifluormethyl)-phenthiazin-10''-yl-(n-prop-3'''ylpiperazin-4''''-yläth-2'''''-yl)]-ester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS6043345B2 (pl) |
AT (1) | AT375355B (pl) |
BE (1) | BE882535A (pl) |
CA (1) | CA1128940A (pl) |
CH (1) | CH643843A5 (pl) |
CS (1) | CS214704B2 (pl) |
DD (1) | DD150060A5 (pl) |
DE (1) | DE3013502C2 (pl) |
ES (1) | ES490315A0 (pl) |
FR (1) | FR2453164A1 (pl) |
GB (1) | GB2047694B (pl) |
HU (1) | HU179190B (pl) |
IT (1) | IT1148812B (pl) |
PL (1) | PL127329B1 (pl) |
SU (1) | SU925250A3 (pl) |
YU (1) | YU42663B (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4471116A (en) * | 1982-07-28 | 1984-09-11 | Hoffmann-La Roche Inc. | Substituted (10H-phenothiazin-10-L)-propyl-1-piperazines |
JPH0568560U (ja) * | 1991-11-05 | 1993-09-17 | 理照 大島 | 握力強化用具 |
JP3932785B2 (ja) | 1999-08-25 | 2007-06-20 | 株式会社村田製作所 | 圧電体の製造方法 |
US20060111346A1 (en) * | 2004-11-23 | 2006-05-25 | Fazix Corporation. | Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL277672A (pl) * | 1961-04-26 |
-
1979
- 1979-04-06 HU HU79GO1442A patent/HU179190B/hu not_active IP Right Cessation
-
1980
- 1980-03-31 BE BE1/9766A patent/BE882535A/fr not_active IP Right Cessation
- 1980-03-31 GB GB8010794A patent/GB2047694B/en not_active Expired
- 1980-04-01 FR FR8007313A patent/FR2453164A1/fr active Granted
- 1980-04-03 AT AT0184080A patent/AT375355B/de not_active IP Right Cessation
- 1980-04-03 DD DD80220206A patent/DD150060A5/de not_active IP Right Cessation
- 1980-04-03 CH CH266180A patent/CH643843A5/de not_active IP Right Cessation
- 1980-04-03 CA CA349,181A patent/CA1128940A/en not_active Expired
- 1980-04-04 IT IT21186/80A patent/IT1148812B/it active
- 1980-04-04 PL PL1980223267A patent/PL127329B1/pl unknown
- 1980-04-04 CS CS802359A patent/CS214704B2/cs unknown
- 1980-04-04 SU SU802903447A patent/SU925250A3/ru active
- 1980-04-04 YU YU933/80A patent/YU42663B/xx unknown
- 1980-04-05 JP JP55044086A patent/JPS6043345B2/ja not_active Expired
- 1980-04-07 ES ES490315A patent/ES490315A0/es active Granted
- 1980-04-08 DE DE3013502A patent/DE3013502C2/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PL127329B1 (en) | 1983-10-31 |
CH643843A5 (de) | 1984-06-29 |
ATA184080A (de) | 1983-12-15 |
CS214704B2 (en) | 1982-05-28 |
YU93380A (en) | 1983-01-21 |
PL223267A1 (pl) | 1981-01-30 |
JPS55153776A (en) | 1980-11-29 |
BE882535A (fr) | 1980-09-30 |
ES8103077A1 (es) | 1981-02-16 |
GB2047694A (en) | 1980-12-03 |
CA1128940A (en) | 1982-08-03 |
ES490315A0 (es) | 1981-02-16 |
IT8021186A0 (it) | 1980-04-04 |
AT375355B (de) | 1984-07-25 |
FR2453164A1 (fr) | 1980-10-31 |
SU925250A3 (ru) | 1982-04-30 |
DD150060A5 (de) | 1981-08-12 |
JPS6043345B2 (ja) | 1985-09-27 |
DE3013502A1 (de) | 1980-10-16 |
IT1148812B (it) | 1986-12-03 |
FR2453164B1 (pl) | 1983-04-15 |
GB2047694B (en) | 1983-02-02 |
YU42663B (en) | 1988-10-31 |
HU179190B (en) | 1982-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1593907C2 (de) | alpha eckige Klammer auf 4-(p-subst.Phenyl>phenoxy eckige Klammer zu -carbonsäuren, deren Derivate sowie diese Verbindungen enthaltende Arzneimittel | |
DE2549783C3 (de) | Triglyceride mit entzündungshemmender Wirkung | |
DE2929777A1 (de) | N-alkylimidazolderivate, verfahren zu ihrer herstellung und solche enthaltende arzneimittel | |
DE68910211T2 (de) | Estramustin-ester. | |
DE2723051C3 (de) | NKAcyO-p-amino-NMn-decyl- und n-tridecyl)-benzamide sowie diese enthaltende Arzneimittel | |
DE3013502C2 (de) | [2''-(Trifluormethyl)-phenthiazin-10''-yl-(n-prop-3'''ylpiperazin-4''''-yläth-2'''''-yl)]-ester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel | |
DE2157272C3 (de) | Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff | |
DE3326724A1 (de) | In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte | |
EP0152868A2 (de) | Isoxazol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0100516B1 (de) | 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE2632118A1 (de) | Apovincaminolester und verfahren zu deren herstellung | |
DE2137538C3 (de) | oxyamin und seine Salze sowie ein Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
DE3026924A1 (de) | 1,3-diphenoxypropan-2-ol-derivate sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
DE2736268A1 (de) | Neue 5-thiazolalkylamin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE1493513C3 (de) | Sulfamylanthranilsäuren, deren therapeutisch verwendbare Salze, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen Präparate | |
DE2410201B2 (de) | 6-substituierte 3-carbaethoxyhydrazinopyridazine beziehungsweise ihre salze sowie solche enthaltende arzneimittel und verfahren zur herstellung derselben | |
DE1801312A1 (de) | Verfahren zur Herstellung einer neuen Aryloxyalkansaeure und ihrer Salze | |
DE3028776A1 (de) | Neue 1,3-diphenoxypropan-2-on-derivate sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
WO1979000116A1 (en) | New glycol compounds for lowering the lipid content | |
DE1801312C (de) | 2 (4 Biphenylyloxy)-heptansaure, ihre Alkali und Erdalkahsalze und diese Verbin düngen enthaltene Arzneimittel | |
DE2022790C3 (de) | 10-Methyl-5-[ (4-Methylpiperazino)-acetyl J-5,10dihydro-llH-dibenzo [b,e ] [1,4 ] diazepin-11-on, ein Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel | |
DE1543639C3 (de) | Verfahren zur Herstellung von substituierten Phenylessigsäure!! und deren Salzen sowie genannte Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
DE2536387A1 (de) | Pyrido(3,2-e)-as-triazinderivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben | |
DE2125113C3 (de) | Bis-(4-chlorphenoxy)-essigsäure-(Nmethyl-pyrrolidyl-2)-methylester und dessen Säureanlagerungssalze, Verfahren zu seiner Herstellung sowie diesen enthaltende Arzneimittel | |
DE1643460C (de) | (3-Trifluormethylphenoxy)-(4-chlorphenyl)-essigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OI | Miscellaneous see part 1 | ||
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |